Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease

K. S. Schiffman, W. I. Bensinger, F. R. Appelbaum, S. Rowley, K. Lilleby, R. A. Clift, C. H. Weaver, T. Demirer, J. E. Sanders, S. Petersdorf, T. Gooley, P. Weiden, N. Zuckerman, P. Montgomery, R. Maziarz, J. P. Klarnet, S. Rivkin, K. Trueblood, R. Storb, L. HolmbergC. D. Buckner

Research output: Contribution to journal › Article › peer-review

53 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease'. Together they form a unique fingerprint.

Medicine & Life Sciences